why choose us

First received: December 07, 2022

Clinical Trial: A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3828136 in Healthy

Brief Summary: Learn about the safety and tolerability of CK-3828136 after a single dose and multiple doses in healthy subjects.Find out how much CK-3828136 is in the blood after a single dose and multiple doses.Determine the effect different doses of CK-3828136 on the pumping function of the heart.

Read more